During the past decade, Laboratoires Théa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Laboratoires Théa" are "Ocular Hypertension" (2 trials), "Cataract" (1 trials), "Dry Eye Syndrome" (1 trials), "Open Angle Glaucoma" (1 trials) and "Primary Open Angle Glaucoma" (1 trials). Many other conditions were trialed in "Laboratoires Théa" in a lesser frequency.

Most popular intervention types in "Laboratoires Théa" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lumigan 0.01%" (1 trials), "Lumigan 0.03% Unit Dose" (1 trials), "Monoprost" (1 trials), "Mydriatics" (1 trials) and "Optive" (1 trials). Other intervention names were less common.

The vast majority of trials in "Laboratoires Théa" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Laboratoires Théa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Laboratoires Théa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Laboratoires Théa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".